A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults
Clinical trial NCT06989788 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06989788
- Sponsor
- AstriVax Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-06
- Primary completion
- 2026-08-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.